Xvivo Perfusion AB (XVIPF)
29.39
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Xvivo Perfusion Market Cap : 925.77M for June 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Getinge AB | 5.150B |
| Paxman AB | 81.46M |
| Enovis Corp. | 1.379B |
| Edwards Lifesciences Corp. | 50.51B |
| IDEXX Laboratories, Inc. | 45.87B |
Market Cap Related Metrics
| PE Ratio | 116.58 |
| PS Ratio | 10.45 |
| Price to Book Value | 4.065 |
| Price to Free Cash Flow | 48.00 |
| Price | 29.39 |
| Earnings Yield | 0.86% |
| Operating PE Ratio | 93.26 |
| Normalized PE Ratio | 117.23 |